Trial intelligence / Profile preview

DLBS1033 vs Aspirin and Clopidogrel in Acute Ischemic Stroke

NCT01790997Phase 3Completed

Sponsor
Dexa Medica
Start
May 2012
Primary completion
Nov 2013
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 3 trial of DLBS1033 in ischemic stroke, sponsored by Dexa Medica. Started May 2012; status: completed.

02

Drugs

DLBS1033
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT01790997.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01790997.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call